Showing results (1651-1660 of 6,770) with videos related to

Sort By:
Pageof 677
Clinical Therapeutics|August 25, 2015
Analysis of prescription pattern and guideline adherence in the management of asthma among medical institutions and physician specialties in Taiwan between 2000 and 2010Chia-Lin Chou, Diahn-Warng Perng, Ting-Lun Lin, et al.
Clinical Therapeutics|April 27, 2016
Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Properties of SBI-087, a CD20-Directed B-cell Depleting Agent: Phase 1 Dose Escalating Studies in Patients With Either Mild Rheumatoid Arthritis or Systemic LupusStanley Cohen, Megan Clowse, Patricia Pardo, et al.
Clinical Therapeutics|April 28, 2016
Development of Clinical Pharmacology in the Russian FederationV I Petrov, I N Kagramanyan, A L Khokhlov, et al.
Clinical Therapeutics|April 23, 2016
Alarmins and Antitumor ImmunityYingjie Nie, De Yang, Joost J Oppenheim
Clinical Therapeutics|February 21, 2016
RGB Measurements From Endoscopic Photography as a New and Objective Diagnostic Method for Chronic TonsillitisAlper Yenigun, Remzi Dogan, Orhan Ozturan, et al.
Clinical Therapeutics|May 26, 2012
Loteprednol etabonate suspension 0.2% administered QID compared with olopatadine solution 0.1% administered BID in the treatment of seasonal allergic conjunctivitis: a multicenter, randomized, investigator-masked, parallel group study in Chinese patientsLan Gong, Xinghuai Sun, Jia Qu, et al.
Clinical Therapeutics|July 23, 2013
A cost-effectiveness analysis of parecoxib in the management of postoperative pain in the Greek health care settingKostas Athanasakis, Ioannis Petrakis, Elli Vitsou, et al.
Clinical Therapeutics|July 23, 2013
Warfarin use and stroke risk among patients with nonvalvular atrial fibrillation in a large managed care populationSteven B Deitelzweig, Erin Buysman, Brett Pinsky, et al.
Clinical Therapeutics|May 5, 2012
Impact of a text messaging pilot program on patient medication adherenceKalee F Foreman, Karen M Stockl, Lisa B Le, et al.
Clinical Therapeutics|May 5, 2012
Are selective serotonin reuptake inhibitors safe for drivers? What is the evidence?Silvia Ravera, Johannes G Ramaekers, Lolkje T W de Jong-van den Berg, et al.
Pageof 677